Skip to content
Medical Health Aged Care

RACGP welcomes Queensland meningococcal B vaccine announcement

Royal Australian College of GPs 2 mins read

The Royal Australian College of General Practitioners (RACGP) has warmly welcomed the Queensland Government making the meningococcal B vaccine free for all infants and children under the age of two, and adolescents aged 15 to 19 years.

Coming into effect next year, the vaccinations will form part of the routine childhood and school immunisation programs for eligible cohorts, as recommended by the Australian Technical Advisory Group on Immunisation, or ATAGI. The National Immunisation Program, or NIP, for infants and adolescents covers the ACWY strains of meningococcal. However, the B strain requires an additional self-funded immunisation for children of normal risk – at a cost of approximately $200 to 300 for the required two doses. South Australia is the only state that funds a vaccination program for meningococcal B for the broader population.

RACGP President Dr Nicole Higgins welcomed the announcement.

“This is great decision from the Queensland Government and one that will potentially save lives,” she said.

Meningococcal B must be taken seriously. This is a rare but terrible disease that without urgent care can result in death or disability. Just a few years ago, a two-year-old died from meningococcal B at my practice and it is something that you never forget. Many people may not realise that meningococcal serogroups B and W are currently responsible for most meningococcal disease in Australia. The B strain is the most common cause of invasive meningococcal disease in children, adolescents, and young adults.

“Between 1997 and 2016, it is estimated that 396 people died from meningococcal disease and 32% of those deaths happened to children aged less than five. It’s a dangerous disease for those who make it through too, 25% of people who get this disease end up with a disability.

“Families have a lot on their plate, and many parents and carers may think that their children are already immunised against this disease. It’s only when they check their children’s immunisation schedules that they realise they are not immunised against meningococcal B. Unfortunately, there just isn’t a high level of awareness in the community that a different vaccine is needed for meningococcal B and that is something I would like to see change because this disease is a killer.

“There is evidence that meningococcal B is emerging as a more common cause of death and one reason may be a result of widespread vaccination in the community against the other meningococcal strains. Meningococcal B must be a priority, so I applaud the Queensland Government for making this investment and encourage all families to take full advantage of the free jabs. Given high cost of living pressures, this announcement could not come at a better time.

“We join AMA Queensland in saying that we hope the federal Government takes note of this timely decision and adds the B strain vaccine to the National Immunisation Program so all young people across Australia are protected from this terrible disease.”

~ENDS

RACGP spokespeople are available for comment.


About us:

About the RACGP

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

Email: [email protected] (we will respond promptly to all requests for interview).

Follow us on Twitter: @RACGP and Facebook.

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

More from this category

  • Medical Health Aged Care
  • 27/04/2025
  • 12:36
Royal Australian College of GPs

GPs back helpline commitment

The Royal Australian College of GPs (RACGP) has welcomed the Albanese Government's announcement to extend a 24/7 helpline and strengthen and improve after-hour links to the GP network. The new nation-wide service, rebadged 1800 Medicare, will be in place from 1 January 2026. Registered nurses will be available 24 hours, a day seven days a week, to provide health advice, refer patients to health services, and in urgent cases, connect them to the patient’s regular GP via phone or video. RACGP President, Dr Michael Wright, backed the announcement. “This is a positive step forward that will help more people access…

  • Medical Health Aged Care
  • 26/04/2025
  • 08:04
Monash University

The power of pets in reducing loneliness and social isolation for at-risk groups

A new pilot program funded by the National Centre for Healthy Ageing (NCHA), a partnership between Monash University and Peninsula Health, is the first to use a shared interest in pets to help build connections between young and older adults to reduce loneliness and social isolation. Social isolation and loneliness stem from a reduced sense of belonging, due to a lack of social connections, and can lead to detrimental effects on physical health and cognitive decline. These experiences have been exacerbated due to the COVID-19 pandemic. Two of the most impacted groups in relation to social isolation and loneliness are…

  • Medical Health Aged Care
  • 25/04/2025
  • 18:11
Elixir Medical Corporation

Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia

First cases completed by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD, and transmitted live at TCTAP Congress in Seoul, Korea.Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary artery lesions without requiring an external energy source.MILPITAS, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced the first clinical use of its LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in the Asia Pacific region, marking a significant milestone in the device's global introduction. The procedures were successfully performed…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.